Supporting Quality Data Systems: Lessons Learned from Early Implementation of Routine Viral Load Monitoring at a Large Clinic in Lilongwe, Malawi
Journal Title: Journal of Clinical Research in HIV AIDS and Prevention - Year 2017, Vol 3, Issue 1
Abstract
Successful viral load programs rely on the presence of data systems and high quality of patient data. Using a cohort of 49 patients at Partners in Hope, a large, urban HIV clinic in Malawi, we performed a quality improvement assessment of a new viral load program with a focus on accuracy of data collected from patients as well as adherence to Malawi HIV Guidelines in regard to response to elevated viral loads (≥1,000 copies/mL). Data were obtained from three parallel medical record systems to investigate the proportion of patients with a repeat viral load and whether the three data systems agreed in regard to sociodemographic and clinical data. Fewer than 30% of patients had a repeat viral load within six months, as recommended in the Malawi HIV Guidelines. There were significant problems with data agreement across the three parallel databases used for care. Date of birth was consistent for 55.1% (N=27) of patients, while a different date of birth was noted in all three sources for 10.2% of patients (N=5). Viral load data from all three sources agreed for only 2.0% of patients (N=1). For 65.3% (N=32), the viral load from the laboratory did not match the recorded viral load in the electronic or paper record. Scale-up of viral load monitoring must be accompanied by the development of data systems that support workflow from sample collection to lab and back to provider. Education of providers and strategies for data collection with minimal errors can facilitate scale-up of high quality programs.
Authors and Affiliations
Jean Gibb, Jimmy Chitsulo, Chifundo Chipungu, Mackenzie Chivwara, Alan Schooley, Risa M. Hoffman
Keywords
Related Articles
- EP ID EP263117
- DOI 10.14302/issn.2324-7339.jcrhap-17-1468
- Views 105
- Downloads 0
Rhabdomyolysis in a HIV-infected Patient Following the Addition of Raltegravir, A Case Report with Review of the Literature
Antiretrovirals have traditionally been associated with much toxicity. Newer antiretrovirals are considered much less toxic relative to older antiretrovirals. Upon its FDA-approval in 2009, raltegravir’s adverse drug rea...
Sociocultural Issues as Barriers to HIV-Infected Orphan Care in Southern Africa
As advances in treatment and prevention are starting to decrease the magnitude of the Acquired Immunodeficiency Syndrome (AIDS) epidemic in Sub-Saharan Africa, the number of orphans and children surviving Human Immunodef...
Single Nucleotide Polymorphisms Associated with Alimentary Fatty Liver Disease are not Genetic Risk Factors for Treatment-associated Hepatic Steatosis in HIV Patients on HAART
No Abstract
The Psychosocial Factors that Influencing Antiretroviral Treatment Adherence
The socio-cultural context of illness has become a major research area, and it has made significant contributions to our understanding of the socio-cultural dimensions of illness. In this article, we briefly trace the ro...
Cardiovascular Risk Factors Among People Being Treated for HIV in Nepal: A Cross-Sectional Study
Background: Human Immunodeficiency Virus (HIV) and antiretroviral therapy (ART) are found to be strongly associated with cardiovascular diseases. Data are sparse on the prevalence and distribution of cardiovascular risk...